These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
377 related items for PubMed ID: 24815833
1. Expression of claudins-1, -4, -5, -7 and occludin in hepatocellular carcinoma and their relation with classic clinicopathological features and patients' survival. Bouchagier KA, Assimakopoulos SF, Karavias DD, Maroulis I, Tzelepi V, Kalofonos H, Karavias DD, Kardamakis D, Scopa CD, Tsamandas AC. In Vivo; 2014; 28(3):315-26. PubMed ID: 24815833 [Abstract] [Full Text] [Related]
2. [Claudins as prognostic factors of breast cancer]. Szász MA. Magy Onkol; 2012 Sep; 56(3):209-12. PubMed ID: 23139925 [Abstract] [Full Text] [Related]
8. Myeloid differentiation factor 88 promotes growth and metastasis of human hepatocellular carcinoma. Liang B, Chen R, Wang T, Cao L, Liu Y, Yin F, Zhu M, Fan X, Liang Y, Zhang L, Guo Y, Zhao J. Clin Cancer Res; 2013 Jun 01; 19(11):2905-16. PubMed ID: 23549880 [Abstract] [Full Text] [Related]
10. Expression of claudin 10 protein in hepatocellular carcinoma: impact on survival. Huang GW, Ding X, Chen SL, Zeng L. J Cancer Res Clin Oncol; 2011 Aug 01; 137(8):1213-8. PubMed ID: 21647678 [Abstract] [Full Text] [Related]
14. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy. Lv Y, Wang W, Jia WD, Sun QK, Huang M, Zhou HC, Xia HH, Liu WB, Chen H, Sun SN, Xu GL. Eur J Surg Oncol; 2013 Oct 01; 39(10):1129-35. PubMed ID: 23916473 [Abstract] [Full Text] [Related]
16. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Sumie S, Kuromatsu R, Okuda K, Ando E, Takata A, Fukushima N, Watanabe Y, Kojiro M, Sata M. Ann Surg Oncol; 2008 May 01; 15(5):1375-82. PubMed ID: 18324443 [Abstract] [Full Text] [Related]
18. Serum and tissue vascular endothelial growth factor predicts prognosis in hepatocellular carcinoma patients after partial liver resection. Zhong C, Wei W, Su XK, Li HD, Xu FB, Guo RP. Hepatogastroenterology; 2012 May 01; 59(113):93-7. PubMed ID: 22251524 [Abstract] [Full Text] [Related]
19. [CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy]. Wang ZS, Wu LQ, Yi X, Geng C, Li YJ, Yao RY, Hu WY, Han B. Zhonghua Zhong Liu Za Zhi; 2012 Oct 01; 34(10):753-8. PubMed ID: 23291069 [Abstract] [Full Text] [Related]
20. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma. Nakanishi K, Sakamoto M, Yamasaki S, Todo S, Hirohashi S. Cancer; 2005 Jan 15; 103(2):307-12. PubMed ID: 15593087 [Abstract] [Full Text] [Related] Page: [Next] [New Search]